Skip to main content
Caplight Logo









BioCity Biopharma

BioCity Biopharma

Private
WuxiHealthcare & Life Scienceshttps://biocitypharma.com/

Total Funding Raised

$21M

Company Overview

BioCity Biopharma is a clinical-stage biopharmaceutical company that develops novel and highly differentiated, modality-independent therapeutic candidates to treat cancer and nephropathy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

clinical-stage biopharmaoncology therapeuticsnephrology therapeuticsantibody-drug conjugateADCchronic kidney diseaseCKDsolid tumor therapycancer drugssmall molecule drugsdrug licensingpharma co-developmentbispecific antibodymonoclonal antibodyETA receptor antagonistWEE1 inhibitorATR kinase inhibitor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioCity Biopharma Comparables

Compare BioCity Biopharma with similar companies based on industry and business-model similarity.

BioCity Biopharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mandeville Therapeutics
73%
Otsuka Holdings
71%
Novartis
71%

BioCity Biopharma Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Yong-jiang Hei

Co-CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 230% MoM.

  • Feb 24, 2025

    Monthly visitors increased 115% MoM, reaching 2.1K.

BioCity Biopharma Filings

Explore SEC and related filing metadata, where available.

BioCity Biopharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioCity Biopharma's valuation, stock price, and market status.

Is BioCity Biopharma a public or private company?

BioCity Biopharma is a private company.

What is the current stock price of BioCity Biopharma?

BioCity Biopharma is a private company with no public stock price. No recent secondary market data is available.

How much is BioCity Biopharma worth (valuation)?

Valuation information for BioCity Biopharma is not publicly available.

Can I buy BioCity Biopharma stock?

BioCity Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioCity Biopharma's last funding round?

Funding round information for BioCity Biopharma is not publicly available.

Who are the main investors in BioCity Biopharma?

Investor information for BioCity Biopharma is not publicly disclosed.

Will BioCity Biopharma IPO soon?

No public IPO plans have been announced for BioCity Biopharma.

How can I track BioCity Biopharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioCity Biopharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWuxi
Employee Range7
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?